224 related articles for article (PubMed ID: 26902808)
1. A vital role for myosin-9 in puromycin aminonucleoside-induced podocyte injury by affecting actin cytoskeleton.
Yuan Y; Zhao C; An X; Wu L; Wang H; Zhao M; Bai M; Duan S; Zhang B; Zhang A; Xing C
Free Radic Res; 2016 Jun; 50(6):627-37. PubMed ID: 26902808
[TBL] [Abstract][Full Text] [Related]
2. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
[TBL] [Abstract][Full Text] [Related]
3. Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases.
Dong N; Meng L; Xue R; Yu M; Zhao Z; Liu X
Int Urol Nephrol; 2017 Aug; 49(8):1489-1506. PubMed ID: 28528353
[TBL] [Abstract][Full Text] [Related]
4. A vital role for Angptl3 in the PAN-induced podocyte loss by affecting detachment and apoptosis in vitro.
Dai R; Lin Y; Liu H; Rao J; Zhai Y; Zha X; Fang X; Xu H
BMC Nephrol; 2015 Mar; 16():38. PubMed ID: 25884163
[TBL] [Abstract][Full Text] [Related]
5. Induction of antioxidant enzymes in murine podocytes precedes injury by puromycin aminonucleoside.
Vega-Warner V; Ransom RF; Vincent AM; Brosius FC; Smoyer WE
Kidney Int; 2004 Nov; 66(5):1881-9. PubMed ID: 15496159
[TBL] [Abstract][Full Text] [Related]
6. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
[TBL] [Abstract][Full Text] [Related]
7. Puromycin aminonucleoside-induced podocyte injury is ameliorated by the Smad3 inhibitor SIS3.
Jiang L; Cui H; Ding J; Yang A; Zhang Y
FEBS Open Bio; 2020 Aug; 10(8):1601-1611. PubMed ID: 32583562
[TBL] [Abstract][Full Text] [Related]
8. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
Shibata S; Nagase M; Fujita T
J Am Soc Nephrol; 2006 Mar; 17(3):754-64. PubMed ID: 16452496
[TBL] [Abstract][Full Text] [Related]
9. Smad3/Nox4-mediated mitochondrial dysfunction plays a crucial role in puromycin aminonucleoside-induced podocyte damage.
Yu L; Liu Y; Wu Y; Liu Q; Feng J; Gu X; Xiong Y; Fan Q; Ye J
Cell Signal; 2014 Dec; 26(12):2979-91. PubMed ID: 25229402
[TBL] [Abstract][Full Text] [Related]
10. Hirudin attenuates puromycin aminonucleoside-induced glomerular podocyte injury by inhibiting MAPK-mediated endoplasmic reticulum stress.
Long C; Lin Q; Mo J; Xiao Y; Xie Y
Drug Dev Res; 2022 Jun; 83(4):1047-1056. PubMed ID: 35277865
[TBL] [Abstract][Full Text] [Related]
11. The cytoprotective role of autophagy in puromycin aminonucleoside treated human podocytes.
Kang YL; Saleem MA; Chan KW; Yung BY; Law HK
Biochem Biophys Res Commun; 2014 Jan; 443(2):628-34. PubMed ID: 24333414
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of nestin protects podocytes from apoptosis induced by puromycin aminonucleoside.
Wen D; You L; Zhang Q; Zhang L; Gu Y; Hao CM; Chen J
Am J Nephrol; 2011; 34(5):423-34. PubMed ID: 21952051
[TBL] [Abstract][Full Text] [Related]
13. Newly identified cytoskeletal components are associated with dynamic changes of podocyte foot processes.
Miao J; Fan Q; Cui Q; Zhang H; Chen L; Wang S; Guan N; Guan Y; Ding J
Nephrol Dial Transplant; 2009 Nov; 24(11):3297-305. PubMed ID: 19617259
[TBL] [Abstract][Full Text] [Related]
14. [Establishment of a podocyte cell injury model induced by puromycin aminonucleoside].
Liu SF; Ding J; Fan QF; Zhang H
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 40(6):586-9. PubMed ID: 19088828
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin inhibitors ameliorate PAN-induced podocyte injury through the NFAT-Angptl4 pathway.
Shen X; Zhang Y; Lin C; Weng C; Wang Y; Feng S; Wang C; Shao X; Lin W; Li B; Wang H; Chen J; Jiang H
J Pathol; 2020 Nov; 252(3):227-238. PubMed ID: 32686149
[TBL] [Abstract][Full Text] [Related]
16. Puromycin aminonucleoside increases podocyte permeability by modulating ZO-1 in an oxidative stress-dependent manner.
Ha TS; Park HY; Seong SB; Ahn HY
Exp Cell Res; 2016 Jan; 340(1):139-49. PubMed ID: 26683996
[TBL] [Abstract][Full Text] [Related]
17. Trehalose, an mTOR independent autophagy inducer, alleviates human podocyte injury after puromycin aminonucleoside treatment.
Kang YL; Saleem MA; Chan KW; Yung BY; Law HK
PLoS One; 2014; 9(11):e113520. PubMed ID: 25412249
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.
Shen X; Jiang H; Ying M; Xie Z; Li X; Wang H; Zhao J; Lin C; Wang Y; Feng S; Shen J; Weng C; Lin W; Wang H; Zhou Q; Bi Y; Li M; Wang L; Zhu T; Huang X; Lan HY; Zhou J; Chen J
Sci Rep; 2016 Sep; 6():32087. PubMed ID: 27580845
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of markers of podocyte injury in the rat puromycin aminonucleoside nephropathy model.
Kakimoto T; Okada K; Fujitaka K; Nishio M; Kato T; Fukunari A; Utsumi H
Exp Toxicol Pathol; 2015 Feb; 67(2):171-7. PubMed ID: 25481214
[TBL] [Abstract][Full Text] [Related]
20. Podocyte injury is suppressed by 1,25-dihydroxyvitamin D via modulation of transforming growth factor-beta 1/bone morphogenetic protein-7 signalling in puromycin aminonucleoside nephropathy rats.
Xiao HQ; Shi W; Liu SX; Zhang B; Xu LX; Liang XL; Liang YZ
Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):682-9. PubMed ID: 19594554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
